Evidence map›Paper›PMID 32414754›Full record

ArticleCancer research2020

State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Development of Acute Myeloid Leukemia.

Russell C Rockne, Sergio Branciamore, Jing Qi, David E Frankhouser, Denis O'Meally, Wei-Kai Hua, Guerry Cook, Emily Carnahan, Lianjun Zhang, Ayelet Marom and 10 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Tipping the Balance: A Criticality Perspective.Entropy (Basel, Switzerland) · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Russell C Rockne *Division of Mathematical Oncology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope Medical Center, Duarte, California. rrockne@coh.org ykuo@coh.org.ORCID 0000-0002-1557-159X
Sergio Branciamore *Department of Diabetes Complications & Metabolism, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Jing Qi *Department of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
David E FrankhouserDepartment of Diabetes Complications & Metabolism, Beckman Research Institute, City of Hope Medical Center, Duarte, California.ORCID 0000-0002-8233-5853
Denis O'MeallyCenter for Gene Therapy, Beckman Research Institute, City of Hope Medical Center, Duarte, California.ORCID 0000-0001-7749-9506
Wei-Kai HuaDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Guerry CookDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Emily CarnahanDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Lianjun ZhangDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Ayelet MaromDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Herman WuDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Davide MaestriniDivision of Mathematical Oncology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope Medical Center, Duarte, California.ORCID 0000-0002-6030-4706
Xiwei WuDepartment of Molecular Medicine; Bioinformatics Core, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Yate-Ching YuanDepartment of Molecular Medicine; Bioinformatics Core, Beckman Research Institute, City of Hope Medical Center, Duarte, California.ORCID 0000-0002-3698-9784
Zheng LiuDepartment of Molecular and Cellular Biology; Integrative Genomics Core, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Leo D WangDepartment of Immuno-Oncology, Beckman Research Institute, City of Hope Medical Center, Duarte, California.ORCID 0000-0002-2945-9005
Stephen FormanDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Nadia CarlessoDepartment of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
Ya-Huei Kuo *Department of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California. rrockne@coh.org ykuo@coh.org.ORCID 0000-0003-2595-0419
Guido Marcucci *Department of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.
City of Hope · USCity Of Hope National Medical Center · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Targeting MicroRNAs to Eradicate Leukemia Stem CellsR01CA205247 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KUO, YA-HUEI, MARCUCCI, GUIDO · 2017 to 2025
$4.8M
Information flow and state transitions at the system and multi-dimensional scales in leukemia progressionU01CA250046 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KUO, YA-HUEI, MARCUCCI, GUIDO · 2020 to 2024
$3.6M
Inflammation as determinant of clonal selection in MPN progressionR01HL141379 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI CARLESSO, NADIA · 2018 to 2021
$2.1M
Cancer Metabolism Training ProgramT32CA221709 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI David K. Ann, Victoria L. Seewaldt · 2018 to 2026
$1.8M
Physiologic Regulation of Hematopoiesis by NotchR01DK097837 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI CARLESSO, NADIA · 2014 to 2017
$1.6M
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and MaintenanceR01CA178387 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KUO, YA-HUEI · 2014 to 2018
$1.6M
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cellsK08CA201591 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WANG, LEO D. · 2017 to 2021
$848k
NCI NIH HHS K08 CA201591NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA178387NCI NIH HHS R01 CA205247NCI NIH HHS T32 CA221709NCI NIH HHS U01 CA250046NHLBI NIH HHS R01 HL141379NIDDK NIH HHS R01 DK097837
6 · The paper itself

Abstract

Temporal dynamics of gene expression inform cellular and molecular perturbations associated with disease development and evolution. Given the complexity of high-dimensional temporal genomic data, an analytic framework guided by a robust theory is needed to interpret time-sequential changes and to predict system dynamics. Here we model temporal dynamics of the transcriptome of peripheral blood mononuclear cells in a two-dimensional state-space representing states of health and leukemia using time-sequential bulk RNA-seq data from a murine model of acute myeloid leukemia (AML). The state-transition model identified critical points that accurately predict AML development and identifies stepwise transcriptomic perturbations that drive leukemia progression. The geometry of the transcriptome state-space provided a biological interpretation of gene dynamics, aligned gene signals that are not synchronized in time across mice, and allowed quantification of gene and pathway contributions to leukemia development. Our state-transition model synthesizes information from multiple cell types in the peripheral blood and identifies critical points in the transition from health to leukemia to guide interpretation of changes in the transcriptome as a whole to predict disease progression. SIGNIFICANCE: These findings apply the theory of state transitions to model the initiation and development of acute myeloid leukemia, identifying transcriptomic perturbations that accurately predict time to disease development.

Indexed as

Leukemia, Myeloid, AcuteLeukocytes, MononuclearAnimalsDisease ProgressionGenomicsMiceTranscriptome

Identifiers

PMID32414754
PMCPMC7416495
OpenAlexW3025668994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.